BigHat Biosciences, a Californian biotech with a machine learning (ML)-guided antibody discovery and development platform, ...

US cancer drug developer Werewolf Therapeutics today announced the appointment of Steven Bloom as chief business officer ...

Orforglipron is the first oral small molecule glucagon-like peptide-1 (GLP-1) receptor agonist, taken without food and water ...

Florida biopharma Ligand Pharmaceuticals subsidiary Pelthos Therapeutics is to merge with Channel Therapeutics (NYSE American ...

Swiss pharma major Novartis has discontinued development of its experimental treatment QUC398 for knee osteoarthritis, ending ...

India’s Venus Remedies has secured Qualified Infectious Disease Product designation from the United States Food and Drug ...

Indian drugmaker Biocon (BSE: 532523) subsidiary Biocon Biologics has announced a settlement and license agreement with the ...

Switzerland-based Addex Therapeutics, a biopharma developing a portfolio of novel small molecule allosteric modulators for ...

Advisory Committee on Immunization Practices (ACIP) has voted to expand its recommendation for the use of respiratory ...

Japanese drugmaker Chugai Pharmaceutical (TYO: 4519) announced that results from the Phase III clinical trial (NIHONBASHI ...

US gene therapy company bluebird bio (Nasdaq: BLUE) announced that after three weeks of engagement, including a timeline ...

Germany’s Evotec has unveiled a new strategy, and provided 2025 guidance—bolstered by strong results from the fourth-quarter of 2024.